Atopic Dermatitis Eczema
Conditions
Brief summary
Atopic dermatitis is a chronic disease with a high impact on patient's quality of life. Nocturnal pruritus is one of the main symptoms affecting quality of life. Treatment efficacy is generally measured by healthcare professionals during consultations with both questioning and visual examination of the lesions. Quality of Life (QoL) can also be evaluated retrospectively with the Dermatology Life Quality Index (DLQI) scale. Collecting data retrospectively introduces a significant recall bias that can be addressed by collecting data in Real World (RW). Real World data collection is prospective and take place within the patient's own environment. While data collection is generally done with diaries, it has been demonstrated that smartphone and connected devices were able to produce more precise and granular data than traditional methods.
Detailed description
The main objective of the study is to demonstrate a medical hypothesis using a wristband actigraph: patients with moderate to severe atopic dermatitis have a poorer quality and quantity of sleep than healthy subject. Secondary objetives are to assess the interest of a smartphone application in evaluating the quality of life of patients with moderate to severe atopic dermatitis in regard of those of healthy volunteers.
Interventions
OTHERelectronic-Patient Report Outcome and wear of a wristband actigraph
Measurement of sleep quality and quantity with wristband actigraph and evaluation of quality of life with electronic-Patient Report Outcome
Sponsors
Ad scientiam
Study design
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE
Intervention model description
Investigators will first enroll patients, then healthy volunters. Healthy volunters will be matched to patients on age, sexe and wake up at a programmed time
Eligibility
Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes
Inclusion criteria
Patients : * Subjects using a smartphone running Apple operating system (iOS 7 and above) or Android (version 2.2 and above) * Subjects agreeing to wear the actigraphy wristband at night * Subjects 18 years old or older * Subjects affiliated to French Health Insurance * Subjects treated for moderate to severe atopic dermatitis or atopic dermatitis exacerbation\* \*The stage of the atopic dermatitis will be assessed by using the Eczema Area and Severity Index (EASI), Body Surface Area (BSA) and Investigator Global Assessment (IGA). The EASI is an investigator-assessed instrument measuring the severity of clinical signs in atopic dermatitis. The EASI was identified as one of the best-validated outcome measures for atopic dermatitis. A moderate to severe atopic dermatitis corresponds to: * Eczema Area and Severity Index score ≥ 7.1 * Investigator Global Assessment ≥ 3 * Body Surface Area ≥ 10 Healthy volunters : * Subjects using a smartphone running iOS (iOS 7 and above) or Android (version 2.2 and above) * Subjects agreeing to wear the actigraphy wristband at night * Subjects 18 years old or older * Subjects affiliated to French Health Insurance * Subjects without a dermatology disease Non inclusion Criteria: * -Illiterate subjects * Subjects not proficient in French * Subject with a primary insomnia\* \*Insomnia, sleep apnea and hypersomnia will be evaluated with respectively 3 tests: * Insomnia Severity Index (ISI); * Berlin Sleep Apnea Scale; * Epworth Scale * Subjects treated by hypnotic drugs * Pregnant woman * Subjects under guardianship
Exclusion criteria
If a participant is taking hypnotic treatments during his study participation, he will be excluded from the clinical trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sleep quality | 15 days | Measure of sleep quality |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sleep quantity | 15 days | Measure of sleep quantity |
Other
| Measure | Time frame | Description |
|---|---|---|
| Quality of life | two times a day for 15 days | electronic patient report outcome on a secured mobile application |
Countries
France
Outcome results
None listed